DK169421B1 - Farmaceutisk præparat til oral indgift med kontrolleret afgivelse - Google Patents
Farmaceutisk præparat til oral indgift med kontrolleret afgivelse Download PDFInfo
- Publication number
- DK169421B1 DK169421B1 DK106685A DK106685A DK169421B1 DK 169421 B1 DK169421 B1 DK 169421B1 DK 106685 A DK106685 A DK 106685A DK 106685 A DK106685 A DK 106685A DK 169421 B1 DK169421 B1 DK 169421B1
- Authority
- DK
- Denmark
- Prior art keywords
- granules
- pharmaceutical composition
- coated
- granule
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59048441A JPH0621066B2 (ja) | 1984-03-14 | 1984-03-14 | 3―イソブチリル―2―イソプロピルピラゾロ〔1,5―a〕ピリジンの徐放性医薬品組成物 |
JP4844184 | 1984-03-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK106685D0 DK106685D0 (da) | 1985-03-08 |
DK106685A DK106685A (da) | 1985-09-15 |
DK169421B1 true DK169421B1 (da) | 1994-10-31 |
Family
ID=12803438
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK106685A DK169421B1 (da) | 1984-03-14 | 1985-03-08 | Farmaceutisk præparat til oral indgift med kontrolleret afgivelse |
DK057993A DK169096B1 (da) | 1984-03-14 | 1993-05-18 | Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK057993A DK169096B1 (da) | 1984-03-14 | 1993-05-18 | Rektalt suppositorie med kontrolleret afgivelse af virksomt stof og fremgangsmåde til fremstilling heraf |
Country Status (11)
Country | Link |
---|---|
US (1) | US5151434A (fr) |
EP (2) | EP0156243B1 (fr) |
JP (1) | JPH0621066B2 (fr) |
KR (1) | KR850006130A (fr) |
AU (1) | AU582739B2 (fr) |
DE (2) | DE156243T1 (fr) |
DK (2) | DK169421B1 (fr) |
IE (1) | IE57853B1 (fr) |
NZ (1) | NZ211424A (fr) |
PH (1) | PH21996A (fr) |
ZA (1) | ZA851830B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6263520A (ja) * | 1985-09-14 | 1987-03-20 | Kyorin Pharmaceut Co Ltd | 抗リウマチ剤 |
JPH01153634A (ja) * | 1987-12-10 | 1989-06-15 | Kyorin Pharmaceut Co Ltd | 吸入剤 |
JPH01153633A (ja) * | 1987-12-10 | 1989-06-15 | Kyorin Pharmaceut Co Ltd | 経皮吸収製剤 |
US5213800A (en) * | 1989-02-09 | 1993-05-25 | Diamond Scientific Company | Chlorhexidine disinfectant granules |
JPH0674206B2 (ja) * | 1989-12-28 | 1994-09-21 | 田辺製薬株式会社 | 放出制御型製剤およびその製法 |
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
WO2000018374A1 (fr) * | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Liberation regulee de compositions nanoparticulaires |
US8293277B2 (en) | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
US6720356B2 (en) * | 2001-04-20 | 2004-04-13 | Spencer Feldman | Magnesium di-potassium EDTA complex and method of administration |
AU2003210517A1 (en) | 2002-02-04 | 2003-09-02 | Elan Pharma International, Ltd. | Drug nanoparticles with lysozyme surface stabiliser |
FR2891459B1 (fr) * | 2005-09-30 | 2007-12-28 | Flamel Technologies Sa | Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant |
JP5352452B2 (ja) * | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784683A (en) * | 1971-03-29 | 1974-01-08 | Abbott Lab | Tablet preparation |
JPS5229318B2 (fr) * | 1972-03-30 | 1977-08-01 | ||
JPS5229318A (en) * | 1975-09-01 | 1977-03-05 | Nippon Telegraph & Telephone | Type head for high speed printer or the like |
CA1188505A (fr) * | 1982-08-24 | 1985-06-11 | Kenneth L. Hurley | Dispositif d'alimentation en toner |
US4540566A (en) * | 1984-04-02 | 1985-09-10 | Forest Laboratories, Inc. | Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose |
JPS6263520A (ja) * | 1985-09-14 | 1987-03-20 | Kyorin Pharmaceut Co Ltd | 抗リウマチ剤 |
-
1984
- 1984-03-14 JP JP59048441A patent/JPH0621066B2/ja not_active Expired - Lifetime
-
1985
- 1985-03-07 IE IE593/85A patent/IE57853B1/en not_active IP Right Cessation
- 1985-03-08 AU AU39676/85A patent/AU582739B2/en not_active Expired
- 1985-03-08 DK DK106685A patent/DK169421B1/da not_active IP Right Cessation
- 1985-03-11 PH PH31970A patent/PH21996A/en unknown
- 1985-03-12 EP EP85102826A patent/EP0156243B1/fr not_active Expired - Lifetime
- 1985-03-12 EP EP19900102574 patent/EP0375662A3/fr not_active Withdrawn
- 1985-03-12 ZA ZA851830A patent/ZA851830B/xx unknown
- 1985-03-12 DE DE198585102826T patent/DE156243T1/de active Pending
- 1985-03-12 DE DE8585102826T patent/DE3580774D1/de not_active Expired - Lifetime
- 1985-03-13 NZ NZ211424A patent/NZ211424A/xx unknown
- 1985-03-14 KR KR1019850001636A patent/KR850006130A/ko not_active Application Discontinuation
-
1989
- 1989-12-12 US US07/448,889 patent/US5151434A/en not_active Expired - Lifetime
-
1993
- 1993-05-18 DK DK057993A patent/DK169096B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR850006130A (ko) | 1985-10-02 |
IE850593L (en) | 1985-09-14 |
DE3580774D1 (de) | 1991-01-17 |
DK57993A (da) | 1993-05-18 |
IE57853B1 (en) | 1993-04-21 |
JPS60193913A (ja) | 1985-10-02 |
EP0375662A3 (fr) | 1990-11-07 |
PH21996A (en) | 1988-05-02 |
EP0156243B1 (fr) | 1990-12-05 |
AU3967685A (en) | 1985-09-19 |
EP0375662A2 (fr) | 1990-06-27 |
DK57993D0 (da) | 1993-05-18 |
US5151434A (en) | 1992-09-29 |
DK106685D0 (da) | 1985-03-08 |
NZ211424A (en) | 1988-09-29 |
DE156243T1 (de) | 1986-05-22 |
AU582739B2 (en) | 1989-04-13 |
EP0156243A2 (fr) | 1985-10-02 |
ZA851830B (en) | 1985-11-27 |
JPH0621066B2 (ja) | 1994-03-23 |
DK106685A (da) | 1985-09-15 |
DK169096B1 (da) | 1994-08-15 |
EP0156243A3 (en) | 1987-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK169421B1 (da) | Farmaceutisk præparat til oral indgift med kontrolleret afgivelse | |
JP4749639B2 (ja) | 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法 | |
EP0122077B1 (fr) | Composition pharmaceutique à effet retard | |
US6638535B2 (en) | Modified release formulations containing a hypnotic agent | |
US6117453A (en) | Solid compositions containing polyethylene oxide and an active ingredient | |
CA2321523C (fr) | Procede utilisant des super-desintegrants dans la preparation de capsules ou de comprimes d'efavirenz a dissolution rapide | |
US5540945A (en) | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines | |
US6048547A (en) | Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient | |
IE862493L (en) | Controlled release pharmaceutical preparations | |
CZ284924B6 (cs) | Prostředek s řízeným uvolňováním, který obsahuje morfinovou sůl | |
CN109562072B (zh) | 包括含有盐酸坦索罗辛的缓释丸粒的具有受控的溶出度的用于口服给药的药物制剂 | |
JP2004510812A (ja) | 遅延放出医薬製剤 | |
PL206083B1 (pl) | Farmaceutyczna postać dawkowania zawierająca chlorowodorek tamsulozyny, sposób wytwarzania farmaceutycznej postaci dawkowania oraz jej zastosowanie | |
KR20000069899A (ko) | 속방성 및 미각 차폐성 약제학적 용량 형태 | |
JP2011093938A (ja) | 副作用が低減されたトラネキサム酸製剤 | |
JP2002533396A (ja) | 徐放性ガランタミン組成物 | |
CA2011919A1 (fr) | Materiel d'enrobage regulant la liberation d'une substance active pour les medicaments a action prolongee | |
JP2003510346A (ja) | 新規医薬組成物 | |
CA3107139C (fr) | Compositions a liberation prolongee comprenant du trihexyphenidyle | |
EP0425699B1 (fr) | Preparation orale pouvant etre liberee dans une region appropriee de l'intestin | |
WO1989002738A1 (fr) | Preparation de nifedipine a liberation soutenue | |
PL192950B1 (pl) | Wielocząstkowa postać farmaceutyczna o opóźnionym i stopniowym uwalnianiu, oraz sposób jej wytwarzania | |
AU1456999A (en) | Novel oral dosage form for carvedilol | |
CA2685214A1 (fr) | Forme posologique orale a liberation regulee amelioree | |
WO2004058228A1 (fr) | Composition de fluoxetine a enrobage enterique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |